Does OSIMERTINIB Cause Dyspnoea? 621 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 621 reports of Dyspnoea have been filed in association with OSIMERTINIB (TAGRISSO). This represents 2.2% of all adverse event reports for OSIMERTINIB.
621
Reports of Dyspnoea with OSIMERTINIB
2.2%
of all OSIMERTINIB reports
158
Deaths
327
Hospitalizations
How Dangerous Is Dyspnoea From OSIMERTINIB?
Of the 621 reports, 158 (25.4%) resulted in death, 327 (52.7%) required hospitalization, and 42 (6.8%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 621 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Nausea (610)
Disease progression (607)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which OSIMERTINIB Alternatives Have Lower Dyspnoea Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN